Second, While our findings link WBP1 levels to survival in chemotherapy-treated CRC patients, prospective clinical studies are needed to evaluate the potential of using WBP1 as a biomarker to predict chemotherapy response and guide treatment decisions. Here, WBP1 is linked to colorectal carcinoma.